Abhishesh Kumar Mehata
M. Pharm., Ph.D. in Pharmaceutics, IIT BHU, India & Postdoc UC Davis USA.
M. Pharm., Ph.D. in Pharmaceutics, IIT BHU, India & Postdoc UC Davis USA.
My doctoral research project has centered on the “Development of targeted nanomedicine and nanotheranostics for breast cancer imaging and therapy.” Throughout my Ph.D. journey, I have gained a comprehensive range of technical and research skills. My area of expertise and interest includes the development of novel formulations for drug delivery, imaging, cancer biology, and theranostics, but is not limited to their in vitro characterization and in vivo evaluation in animal models, statistical analysis, and bioanalytical HPLC method development. I have extensive experience in the development of Polymeric NPs, Liquid crystal NPs, Solid lipid NPs, Liposomes, Cubosomes, Exosomes, Metallic NPs (Ag, Au, Ag-Au, Cus, etc.,) and ultrasmall fluorescent nanoclusters. I have hands-on experience in handling experimental animals such as mice, rats, guinea pigs, etc., and in the development of breast tumors and lung tumors by carcinogenic and syngeneic methods.
Biomaterials, Drug Delivery, Targeted Therapy, Diagnosis, Cancer Biology, and Preclinical Testing
PLGA Nanoplatform for the Hypoxic Tumor Delivery: Folate Targeting, Therapy, and Ultrasound/Photoacoustic Imaging. Mehata et al, 2024, ACS Applied Bio materials.
Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation. Mehata et al. 2026, Nanotheranostics